|
|
Scooped by
Lionel Reichardt / le Pharmageek
January 22, 2013 10:59 AM
|
Une veille sur la santé numérique en France et à l’international : politiques publiques, données, infrastructures, IA, services et usages. Études, rapports et retours de terrain sélectionnés par Lionel Reichardt, Pharmageek, pour comprendre les transformations et éclairer les décisions.
Your new post is loading...
Your new post is loading...
No comment yet.
Sign up to comment
Dan Baxter's curator insight,
January 22, 2013 3:40 AM
Going into more detail about the types of features and services doctors would like to see on these platforms, access to pharma websites came top (mentioned by 43 per cent of doctors who use the networks), followed by reaching a SALES REP via email (42 per cent) and watching self-guided online promotional programmes (42 per cent).
This last week – the widely read Dr. Rob Lamberts lamented the usability of his Electronic Medical Record (EMR) software for his new primary care practice. It's worth reading (here) as it highlights the larger systemic problem of EMR software... Via Chatu Jayadewa
gary levin's curator insight,
July 5, 2015 9:02 PM
Digital health is the alphabet....we still need to make sentences, then paragraphs, then at long last a thesis
To explore the applicability of two gestational diabetes management apps for patients: Gestational Diabetes Manager app and Diabetes in Pregnancy app Via Parag Vora
The Little Blue Book… in collaboration with Sharecare has released their 2012 National Physicians Survey…. Not many surprises here: (2012 Physicians Survey :: http://t.co/g4GgBjvR #hcsm)...
Il semblerait bien que les professionnels de santé et les médecins en particulier, ont adopté l’usage des réseaux sociaux dans leur pratique d’internet. Et qui plus est, cela devient un élément imp...
You've heard of investment banks being "Too Big To Fail" as an excuse for government intervention.
La m-santé au cabinet médical - Telle une épidémie, les smartphones envahissent les salles d’attente des médecins. Il n’est plus rare d’y voir 100% des patients tapotant sur leur clavier voire même sur leur tablette. Via Agathe Quignot, Hi_Camille_
The Raiing Wireless Thermometer from China continuously monitors temperatures so you don't have to. No waking up your child to take his temperature every hour. Let him sleep! See how this works: Via Emmanuel Capitaine
Recorded live in front of an audience of 70 medical communications and pharmaceutical professionals in Oxford by the @Digitally_Sick team of Faisal Ahmed (@sickonthenet), Alex Butler (@Alex__Butler) and Andrew Spong (@andrewspong) at the kind invitation of Peter Llewellyn (@NetworkPharma) Via Alex Butler, Chatu Jayadewa
Alex Butler's curator insight,
January 21, 2013 4:22 AM
The first live recorded podcast from Oxford tackles medical communications in an age of social technologies and digital media.
In front of 70 medical communications professionals the team look at the definition of medcomms, what the challenges are at the present time and in the future and what needs to be done to meet these challenges. There is comment and perspective from a lively and engaged audience. |
L’application et l’équipement de Glooko permet aux patients diabétiques d’importer les données récoltées par leur glucomètre directement sur leur téléphone mobile, et de partager les données avec leur médecin en quelques clics. Via L'Atelier
There are still very few examples of branded digital initiatives, aside from the obligatory Facebook page, etc.; however, some of the unbranded programs and tools overall have been impressive. So, is pharma behind the curve ...
With this in mind, it is clear that digital Pharma has come a long way in a fairly short space of time. Brands are really starting to embrace social media platforms and their initiatives show a clear indication that they are beginning ...
34% of physicians email each other but only 20% email patients! #hcsm (34% of physicians email each other but only 20% email patients!
Les Échos
How High Performing Pharma Companies Are Preparing For The “New Normal” http://t.co/TCXIysUg #pharma #patentcliff
This Deloitte report is the third in an annual series exploring the pharmaceutical industry’s performance in generating a return from its investment in new |
Your new post is loading...